WeedMD Signs Multi-year Retail Sales Distribution Deal with Lifford Cannabis Solutions
October 31, 2018 (Source) — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce it has signed a multi-year retail sales distribution agreement with Lifford Cannabis Solutions (“Lifford”), led by long-time cannabis advocate, influencer and media personality Lisa Campbell, to represent WeedMD’s premium cannabis brands and products for the adult-use retail market in British Columbia and Alberta.
“With the onset of legalization, WeedMD’s products are garnering the attention of a discerning and knowledgeable cannabis audience. Lifford has a history of delivering great results in the alcohol beverage category and has developed strong relationships with the provincial distributors as well as key customers,” said Brett Moon, SVP, Sales and Marketing at WeedMD. “Lifford’s strong foundation, coupled with cannabis advocate Lisa Campbell’s expertise and influence will bring WeedMD tremendous value and additional exposure in western Canada’s cannabis markets – ensuring strategic product placement and nation-wide success.”
“Lifford Cannabis Solutions is delighted to be working with WeedMD, a licensed producer widely recognized as a groundbreaking cultivator in Canada. With some of the most unique genetics on the market, we are excited to elevate WeedMD through our four-pillared approach which combines distribution, education, innovation and relationships,” said Lisa Campbell, CEO, Lifford Cannabis Solutions. “We are confident that WeedMD’s top-shelf cannabis – which is sustainably grown by a team that is deeply rooted in the cannabis community – will be well-suited to consumers in the west. It is an honour to collaborate with the WeedMD team as they continue to grow across Canada.”
About Lifford Cannabis Solutions
Lifford Cannabis Solutions was founded by cannabis advocate Lisa Campbell in order to bring the most premium selections of cannabis to consumers. Lifford Cannabis Solutions assists licensed cannabis companies in getting their products successfully through control boards to retail. As subsidiary of Lifford Wine & Spirits, it brings decades of experience to aid cannabis companies coming to market.
Get our daily investorintel update
About WeedMD Inc.
WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer and distributor of cannabis and cannabis oil for both the medical and adult-use markets under the Cannabis Act. The Company operates two facilities: a 26,000 sq. ft. indoor facility in Aylmer, Ontario and a state-of-the-art greenhouse facility located in Strathroy, Ontario. The Greenhouse currently has 44,000 square feet of licensed space in production and is expected to have a total footprint of more than 500,000 square feet online by year-end 2018. WeedMD has a multi-channeled distribution strategy that includes supply agreements with Shoppers Drug Mart and provincial distribution agencies, as well as through strategic relationships across the seniors’ market in Canada.
Forward Looking Information
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation which are based upon WeedMD’s current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as “expect”, “likely”, “may”, “will”, “should”, “intend”, “anticipate”, “potential”, “proposed”, “estimate” and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions “may”, “would” or “will” happen, or by discussions of strategy.
The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of WeedMD to implement its business strategies; competition; crop failure; and other risks.
Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD’s Annual Information Form dated December 13, 2017 (the “AIF”) and other disclosure documents of WeedMD filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the AIF and other disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE
InvestorIntel is a trusted source of reliable information at the forefront of emerging markets that brings investment opportunities to discerning investors.